Literature DB >> 20383182

Clinical trials: percutaneous tibial nerve stimulation for overactive bladder.

Rufus Cartwright, Vik Khullar.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20383182     DOI： 10.1038/nrurol.2010.39

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.

Authors:  Kenneth M Peters; Donna J Carrico; Ramon A Perez-Marrero; Ansar U Khan; Leslie S Wooldridge; Gregory L Davis; Scott A Macdiarmid
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

2.  Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.

Authors:  Kenneth M Peters; Scott A Macdiarmid; Leslie S Wooldridge; Fah Che Leong; S Abbas Shobeiri; Eric S Rovner; Steven W Siegel; Susan B Tate; Barry K Jarnagin; Peter L Rosenblatt; Brian A Feagins
Journal:  J Urol       Date:  2009-07-18       Impact factor: 7.450

3.  Treatment of motor and sensory detrusor instability by electrical stimulation.

Authors:  E J McGuire; S C Zhang; E R Horwinski; B Lytton
Journal:  J Urol       Date:  1983-01       Impact factor: 7.450

4.  Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study.

Authors:  F E Govier; S Litwiller; V Nitti; K J Kreder ; P Rosenblatt
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

5.  Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data.

Authors:  Vera Vandoninck; Michael R van Balken; Enrico Finazzi Agrò; Filomena Petta; Francesco Micali; John P F A Heesakkers; Frans M J Debruyne; Lambertus A L M Kiemeney; Bart L H Bemelmans
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

6.  A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.

Authors:  Dudley Robinson; Linda Cardozo; Gerben Terpstra; John Bolodeoku
Journal:  BJU Int       Date:  2007-10       Impact factor: 5.588

Review 7.  The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.

Authors:  Christopher R Chapple; Vik Khullar; Zahava Gabriel; Dominic Muston; Caty Ebel Bitoun; David Weinstein
Journal:  Eur Urol       Date:  2008-06-20       Impact factor: 20.096

8.  New vs old: descriptors can affect patients' surgical preferences.

Authors:  Mary P FitzGerald; Christina Elliott; Linda Brubaker
Journal:  Am J Obstet Gynecol       Date:  2008-05-12       Impact factor: 8.661

9.  Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.

Authors:  Scott A MacDiarmid; Kenneth M Peters; S Abbas Shobeiri; Leslie S Wooldridge; Eric S Rovner; Fah Che Leong; Steven W Siegel; Susan B Tate; Brian A Feagins
Journal:  J Urol       Date:  2010-01       Impact factor: 7.450
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.